Indeed, increased RORC expression did not correlate with poor survival of AML patients, indicating an independent role of RORC expression level and a functional role in the upregulation of SREBP2, which is responsible for an SREBP2-specific role in leukemia development (Supplementary Fig. 1D). This evidence concerns the gene SREBF2 and acute myeloid leukemia.